Grantham, Mayo, Van Otterloo & Co (GMO)
CLS icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s Celestica CLS Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio CLS Stock Details CLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-36,883
Closed -$2.91M – 627
2025
Q1 		$2.91M Sell
36,883
-331,559
-90% -$35.2M 0.01% 352
2024
Q4 		$34M Sell
368,442
-210,961
-36% -$16.5M 0.11% 122
2024
Q3 		$29.6M Sell
579,403
-92,550
-14% -$4.78M 0.09% 147
2024
Q2 		$38.5M Sell
671,953
-598,486
-47% -$30.2M 0.13% 106
2024
Q1 		$57.1M Sell
1,270,439
-162,343
-11% -$6.16M 0.21% 67
2023
Q4 		$42.1M Buy
1,432,782
+20,201
+1% +$537K 0.19% 99
2023
Q3 		$34.7M Buy
1,412,581
+244,884
+21% +$5.01M 0.16% 114
2023
Q2 		$17M Buy
1,167,697
+114,539
+11% +$1.42M 0.08% 198
2023
Q1 		$13.6M Sell
1,053,158
-54,300
-5% -$695K 0.07% 218
2022
Q4 		$12.5M Buy
1,107,458
+27,500
+3% +$289K 0.07% 213
2022
Q3 		$9.12M Sell
1,079,958
-138,500
-11% -$1.4M 0.05% 244
2022
Q2 		$11.8M Buy
1,218,458
+92,300
+8% +$990K 0.06% 242
2022
Q1 		$13.4M Buy
1,126,158
+120,700
+12% +$1.42M 0.06% 219
2021
Q4 		$11.2M Sell
1,005,458
-1,100
-0.1% -$11.4K 0.05% 234
2021
Q3 		$8.94M Buy
1,006,558
+37,800
+4% +$324K 0.04% 272
2021
Q2 		$7.6M Buy
968,758
+222,200
+30% +$1.85M 0.04% 276
2021
Q1 		$6.24M Buy
746,558
+233,500
+46% +$1.99M 0.03% 283
2020
Q4 		$4.14M Buy
513,058
+58,658
+13% +$429K 0.03% 327
2020
Q3 		$3.13M Buy
454,400
+89,600
+25% +$674K 0.02% 323
2020
Q2 		$2.5M Sell
364,800
-78,800
-18% -$451K 0.02% 368
2020
Q1 		$1.54M Buy
+443,600
New +$3.06M 0.01% 432
2019
Q3 		– Sell
-53,700
Closed -$367K – 736
2019
Q2 		$367K Sell
53,700
-6,500
-11% -$47.4K ﹤0.01% 633
2019
Q1 		$509K Buy
60,200
+13,400
+29% +$120K ﹤0.01% 580
2018
Q4 		$410K Buy
+46,800
New +$469K ﹤0.01% 458
2018
Q3 		– Sell
-10,800
Closed -$128K – 536
2018
Q2 		$128K Sell
10,800
-5,400
-33% -$61.9K ﹤0.01% 544
2018
Q1 		$168K Hold
16,200
– – ﹤0.01% 555
2017
Q4 		$170K Sell
16,200
-23,400
-59% -$259K ﹤0.01% 561
2017
Q3 		$489K Sell
39,600
-57,800
-59% -$712K ﹤0.01% 419
2017
Q2 		$1.32M Sell
97,400
-348,200
-78% -$4.88M 0.01% 351
2017
Q1 		$6.46M Sell
445,600
-98,491
-18% -$1.32M 0.04% 209
2016
Q4 		$6.46M Sell
544,091
-87,409
-14% -$1.02M 0.03% 228
2016
Q3 		$6.82M Sell
631,500
-71,600
-10% -$753K 0.03% 231
2016
Q2 		$6.51M Buy
703,100
+10,600
+2% +$111K 0.03% 271
2016
Q1 		$7.63M Buy
692,500
+309,800
+81% +$3.13M 0.03% 263
2015
Q4 		$4.21M Buy
+382,700
New +$4.41M 0.02% 275
2014
Q3 		– Sell
-34,800
Closed -$438K – 440
2014
Q2 		$438K Sell
34,800
-11,400
-25% -$131K ﹤0.01% 444
2014
Q1 		$506K Sell
46,200
-4,400
-9% -$43.8K ﹤0.01% 508
2013
Q4 		$526K Buy
+50,600
New +$533K ﹤0.01% 539

Other funds holding CLS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WRCM
Whale Rock Capital Management Boston, Massachusetts $7.74B AUM 180.85% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CIBC World Market
CIBC World Market Toronto, Ontario, Canada $61.3B AUM 39.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s CLS Position: Q2 2025 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Celestica (CLS) in Q2 2025, closing a stake of 36,883 shares — an estimated $2.91M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in CLS in Q4 2013 and held it in 38 quarters. The position peaked at $57.1M in Q1 2024. 597 funds tracked by Wall St. Rank hold CLS as of Q2 2025.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Celestica position as of Q2 2025 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 36,883 Celestica shares in Q2 2025, an estimated $2.91M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Celestica in Q4 2013 and held it in 38 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Celestica position peaked at $57.1M in Q1 2024.
  • 597 funds tracked by Wall St. Rank held Celestica as of Q2 2025.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2025, filed 13 Aug 2025.